Hypotriglyceridemia
|
disease |
|
Disease or Syndrome
|
9
|
2
|
0.100 |
None |
|
0 |
|
|
|
Increased HDL cholesterol concentration
|
phenotype |
Nutritional and Metabolic Diseases
|
Finding
|
3
|
|
0.100 |
None |
|
0 |
|
|
|
Adolescent Overweight
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases
|
Finding
|
4
|
|
0.300 |
None |
1.000 |
1 |
|
2014 |
2014 |
Adolescent Obesity
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
18
|
9
|
0.300 |
None |
1.000 |
1 |
|
2014 |
2014 |
Lipidemias
|
phenotype |
Nutritional and Metabolic Diseases
|
Finding
|
18
|
|
0.300 |
None |
1.000 |
1 |
|
1999 |
1999 |
Pediatric Obesity
|
disease |
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
191
|
67
|
0.300 |
None |
1.000 |
1 |
|
2014 |
2014 |
Liver carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
5725
|
942
|
0.300 |
None |
1.000 |
1 |
|
2017 |
2017 |
Atherogenesis
|
phenotype |
Cardiovascular Diseases
|
Pathologic Function
|
59
|
|
0.300 |
None |
1.000 |
1 |
|
2016 |
2016 |
Hyperlipoproteinemia Type IIb
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
25
|
16
|
0.300 |
None |
1.000 |
1 |
|
2005 |
2005 |
Dyslipoproteinemias
|
phenotype |
Nutritional and Metabolic Diseases
|
Pathologic Function
|
24
|
|
0.300 |
None |
1.000 |
1 |
|
2007 |
2007 |
Childhood Overweight
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases
|
Finding
|
4
|
|
0.300 |
None |
1.000 |
1 |
|
2014 |
2014 |
Infant Overweight
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases
|
Finding
|
4
|
|
0.300 |
None |
1.000 |
1 |
|
2014 |
2014 |
Infantile Obesity
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
5
|
|
0.300 |
None |
1.000 |
1 |
|
2014 |
2014 |
Pseudocholinesterase Measurement
|
phenotype |
|
Laboratory Procedure
|
39
|
568
|
0.100 |
None |
1.000 |
1 |
10
|
2011 |
2011 |
Serum LDL cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
269
|
555
|
0.100 |
None |
1.000 |
1 |
3
|
2012 |
2012 |
Asthma
|
disease |
Respiratory Tract Diseases; Immune System Diseases
|
Disease or Syndrome
|
2096
|
1536
|
0.100 |
None |
1.000 |
1 |
1
|
2015 |
2015 |
Lipids measurement
|
group |
|
Laboratory Procedure
|
27
|
53
|
0.100 |
None |
1.000 |
1 |
4
|
2009 |
2009 |
Serum albumin measurement
|
phenotype |
|
Laboratory Procedure
|
433
|
3282
|
0.100 |
None |
1.000 |
1 |
28
|
2012 |
2012 |
Geographic Atrophy
|
disease |
Eye Diseases
|
Disease or Syndrome
|
85
|
81
|
0.100 |
None |
1.000 |
1 |
2
|
2016 |
2016 |
Cholesteryl Ester Transfer Protein Measurement
|
phenotype |
|
Laboratory Procedure
|
1
|
3
|
0.100 |
None |
1.000 |
1 |
2
|
2018 |
2018 |
Body Height
|
phenotype |
|
Organism Attribute
|
1903
|
3972
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Cholesterol measurement test
|
phenotype |
|
Laboratory Procedure
|
1
|
3
|
0.100 |
None |
1.000 |
1 |
1
|
2010 |
2010 |
C-reactive protein measurement
|
phenotype |
|
Laboratory Procedure
|
135
|
624
|
0.100 |
None |
1.000 |
1 |
2
|
2016 |
2016 |
Biliary Tract Cancer
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
167
|
11
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Postinfarction
|
disease |
|
Disease or Syndrome
|
49
|
1
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |